![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NUBP1 |
Gene summary for NUBP1 |
![]() |
Gene information | Species | Human | Gene symbol | NUBP1 | Gene ID | 4682 |
Gene name | nucleotide binding protein 1 | |
Gene Alias | CIAO5 | |
Cytomap | 16p13.13 | |
Gene Type | protein-coding | GO ID | GO:0000226 | UniProtAcc | P53384 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
4682 | NUBP1 | LZE4T | Human | Esophagus | ESCC | 2.14e-06 | 2.33e-01 | 0.0811 |
4682 | NUBP1 | LZE8T | Human | Esophagus | ESCC | 6.02e-07 | 3.68e-01 | 0.067 |
4682 | NUBP1 | LZE20T | Human | Esophagus | ESCC | 3.84e-02 | 1.21e-01 | 0.0662 |
4682 | NUBP1 | LZE24T | Human | Esophagus | ESCC | 8.97e-09 | 2.06e-01 | 0.0596 |
4682 | NUBP1 | LZE6T | Human | Esophagus | ESCC | 5.63e-08 | 2.89e-01 | 0.0845 |
4682 | NUBP1 | P1T-E | Human | Esophagus | ESCC | 1.81e-02 | 2.12e-01 | 0.0875 |
4682 | NUBP1 | P2T-E | Human | Esophagus | ESCC | 1.58e-44 | 8.56e-01 | 0.1177 |
4682 | NUBP1 | P4T-E | Human | Esophagus | ESCC | 1.34e-09 | 2.56e-01 | 0.1323 |
4682 | NUBP1 | P5T-E | Human | Esophagus | ESCC | 9.98e-09 | 2.25e-01 | 0.1327 |
4682 | NUBP1 | P8T-E | Human | Esophagus | ESCC | 8.98e-31 | 5.83e-01 | 0.0889 |
4682 | NUBP1 | P9T-E | Human | Esophagus | ESCC | 1.99e-09 | 1.23e-01 | 0.1131 |
4682 | NUBP1 | P10T-E | Human | Esophagus | ESCC | 2.66e-09 | 1.44e-01 | 0.116 |
4682 | NUBP1 | P11T-E | Human | Esophagus | ESCC | 1.72e-18 | 5.97e-01 | 0.1426 |
4682 | NUBP1 | P12T-E | Human | Esophagus | ESCC | 6.18e-28 | 4.97e-01 | 0.1122 |
4682 | NUBP1 | P15T-E | Human | Esophagus | ESCC | 1.30e-15 | 3.00e-01 | 0.1149 |
4682 | NUBP1 | P16T-E | Human | Esophagus | ESCC | 4.88e-20 | 3.23e-01 | 0.1153 |
4682 | NUBP1 | P17T-E | Human | Esophagus | ESCC | 4.56e-12 | 4.17e-01 | 0.1278 |
4682 | NUBP1 | P19T-E | Human | Esophagus | ESCC | 2.80e-07 | 4.53e-01 | 0.1662 |
4682 | NUBP1 | P20T-E | Human | Esophagus | ESCC | 1.06e-14 | 3.40e-01 | 0.1124 |
4682 | NUBP1 | P21T-E | Human | Esophagus | ESCC | 1.75e-27 | 4.81e-01 | 0.1617 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:199077819 | Esophagus | ESCC | protein localization to cell periphery | 217/8552 | 333/18723 | 4.08e-13 | 1.88e-11 | 217 |
GO:0016049110 | Esophagus | ESCC | cell growth | 289/8552 | 482/18723 | 1.29e-10 | 3.77e-09 | 289 |
GO:00457865 | Esophagus | ESCC | negative regulation of cell cycle | 236/8552 | 385/18723 | 3.62e-10 | 9.93e-09 | 236 |
GO:0010639110 | Esophagus | ESCC | negative regulation of organelle organization | 215/8552 | 348/18723 | 8.20e-10 | 2.01e-08 | 215 |
GO:000155819 | Esophagus | ESCC | regulation of cell growth | 248/8552 | 414/18723 | 2.97e-09 | 6.45e-08 | 248 |
GO:00067906 | Esophagus | ESCC | sulfur compound metabolic process | 201/8552 | 339/18723 | 2.64e-07 | 3.94e-06 | 201 |
GO:00109484 | Esophagus | ESCC | negative regulation of cell cycle process | 177/8552 | 294/18723 | 3.26e-07 | 4.59e-06 | 177 |
GO:00618428 | Esophagus | ESCC | microtubule organizing center localization | 28/8552 | 33/18723 | 3.80e-06 | 4.12e-05 | 28 |
GO:00070982 | Esophagus | ESCC | centrosome cycle | 85/8552 | 130/18723 | 4.41e-06 | 4.69e-05 | 85 |
GO:00310233 | Esophagus | ESCC | microtubule organizing center organization | 92/8552 | 143/18723 | 5.04e-06 | 5.31e-05 | 92 |
GO:00516428 | Esophagus | ESCC | centrosome localization | 27/8552 | 32/18723 | 7.10e-06 | 7.12e-05 | 27 |
GO:005507617 | Esophagus | ESCC | transition metal ion homeostasis | 87/8552 | 138/18723 | 2.85e-05 | 2.37e-04 | 87 |
GO:001622611 | Esophagus | ESCC | iron-sulfur cluster assembly | 21/8552 | 26/18723 | 2.69e-04 | 1.63e-03 | 21 |
GO:003116311 | Esophagus | ESCC | metallo-sulfur cluster assembly | 21/8552 | 26/18723 | 2.69e-04 | 1.63e-03 | 21 |
GO:00469169 | Esophagus | ESCC | cellular transition metal ion homeostasis | 70/8552 | 115/18723 | 7.28e-04 | 3.79e-03 | 70 |
GO:00328864 | Esophagus | ESCC | regulation of microtubule-based process | 134/8552 | 240/18723 | 9.44e-04 | 4.80e-03 | 134 |
GO:00550729 | Esophagus | ESCC | iron ion homeostasis | 52/8552 | 85/18723 | 2.86e-03 | 1.21e-02 | 52 |
GO:001604917 | Oral cavity | OSCC | cell growth | 268/7305 | 482/18723 | 6.55e-14 | 3.51e-12 | 268 |
GO:199077816 | Oral cavity | OSCC | protein localization to cell periphery | 190/7305 | 333/18723 | 1.46e-11 | 5.13e-10 | 190 |
GO:000155816 | Oral cavity | OSCC | regulation of cell growth | 228/7305 | 414/18723 | 1.74e-11 | 6.09e-10 | 228 |
Page: 1 2 3 4 5 6 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NUBP1 | SNV | Missense_Mutation | novel | c.144N>T | p.Glu48Asp | p.E48D | P53384 | protein_coding | tolerated(0.21) | benign(0.199) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
NUBP1 | SNV | Missense_Mutation | c.725C>A | p.Ser242Tyr | p.S242Y | P53384 | protein_coding | deleterious(0) | probably_damaging(0.954) | TCGA-BS-A0UF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
NUBP1 | SNV | Missense_Mutation | novel | c.476A>G | p.Asp159Gly | p.D159G | P53384 | protein_coding | deleterious(0) | benign(0.071) | TCGA-EY-A2OM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | taxol | SD |
NUBP1 | SNV | Missense_Mutation | rs148166867 | c.602C>T | p.Pro201Leu | p.P201L | P53384 | protein_coding | deleterious(0.02) | probably_damaging(1) | TCGA-69-7765-01 | Lung | lung adenocarcinoma | Male | <65 | III/IV | Chemotherapy | carboplatin | SD |
NUBP1 | SNV | Missense_Mutation | c.634G>C | p.Glu212Gln | p.E212Q | P53384 | protein_coding | deleterious(0.04) | probably_damaging(0.913) | TCGA-75-6214-01 | Lung | lung adenocarcinoma | Female | Unknown | III/IV | Unknown | Unknown | PD | |
NUBP1 | SNV | Missense_Mutation | c.185N>T | p.Gly62Val | p.G62V | P53384 | protein_coding | deleterious(0) | probably_damaging(0.946) | TCGA-91-A4BC-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
NUBP1 | SNV | Missense_Mutation | novel | c.583N>T | p.Ala195Ser | p.A195S | P53384 | protein_coding | deleterious(0.04) | possibly_damaging(0.458) | TCGA-90-7964-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
NUBP1 | SNV | Missense_Mutation | novel | c.316N>A | p.Glu106Lys | p.E106K | P53384 | protein_coding | tolerated(0.1) | benign(0.434) | TCGA-CN-6996-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
NUBP1 | SNV | Missense_Mutation | novel | c.877A>T | p.Thr293Ser | p.T293S | P53384 | protein_coding | tolerated(0.47) | benign(0.06) | TCGA-CR-7364-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
NUBP1 | SNV | Missense_Mutation | c.440N>T | p.Pro147Leu | p.P147L | P53384 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-BR-4257-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |